Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression-Reference-Cited by-同舟云学术

Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression

Published:2020-12-17 Issue:5 Volume:26 Page:461-468
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Stock Carmel J.W.¹^ORCID,Hoyles Rachel K.²,Daccord Cecile¹³,Kokosi Maria¹,Visca Dina¹⁴,De Lauretis Angelo¹⁵,Alfieri Veronica¹⁶,Kouranos Vasilis¹,Margaritopoulos George¹,George Peter M.¹,Molyneaux Philip L.¹,Chua Felix¹,Maher Toby M.¹^ORCID,Abraham David J.⁷,Ong Voon⁷,Donovan Jackie⁸,Sestini Piersante⁹,Denton Christopher P.⁷,Wells Athol U.¹^ORCID,Renzoni Elisabetta A.¹^ORCID

Affiliation:

1. Interstitial Lung Disease Unit Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London UK

2. Oxford Centre for Respiratory Medicine Oxford University Hospitals Oxford UK

3. Division of Respiratory Medicine Lausanne University Hospital (CHUV) Lausanne Switzerland

4. Division of Pulmonary Rehabilitation Istituti Clinici Scientifici Maugeri, IRCCS Tradate Italy

5. Unita' Operativa Malattie Respiratorie Ospedale Guido Salvini Milan Italy

6. Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery University of Parma Parma Italy

7. Centre for Rheumatology and Connective Tissue Diseases Royal Free and University College Medical School London UK

8. Department of Biochemistry Royal Brompton Hospital London UK

9. Department of Medicine, Surgery and Neuroscience University of Siena Siena Italy

Funder

Versus Arthritis

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.13988

Reference36 articles.

1. Relationship between cutaneous and pulmonary involvement in systemic sclerosis;Morelli S;J. Rheumatol.,1997

2. New Serum Indicator of Interstitial Pneumonitis Activity

3. Monitoring of Serum KL-6 Antigen in a Patient with Radiation Pneumonia

4. Serum levels of KL‐6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis;Yamane K;J. Rheumatol.,2000

5. Longitudinal analysis of serum KL‐6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis;Yanaba K;Clin. Exp. Rheumatol.,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic sclerosis and interstitial lung disease: From pathogenesis, to screening, diagnosis, and classification;Revista Colombiana de Reumatología;2023-10

2. Treatable Traits in Systemic Sclerosis;Clinical Reviews in Allergy & Immunology;2023-08-21

3. Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: A narrative review;Revista Colombiana de Reumatología;2023-08

4. Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-19;BMJ Open Respiratory Research;2023-05

5. Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis;Clinical Biochemistry;2023-04